Table of Contents Author Guidelines Submit a Manuscript
Emergency Medicine International
Volume 2016, Article ID 6091510, 6 pages
http://dx.doi.org/10.1155/2016/6091510
Research Article

Using Fresh Frozen Plasma for Acute Airway Angioedema to Prevent Intubation in the Emergency Department: A Retrospective Cohort Study

1Department of Internal Medicine, St. John Hospital & Medical Center, 22101 Moross Road, Detroit, MI 48236, USA
2Geriatric Research Education and Clinical Center (GRECC), VA Ann Arbor Healthcare System, 2215 Fuller Road 11 G, Ann Arbor, MI 48105, USA
3Department of Internal Medicine, University of Michigan, 3110 Taubman Center, SPC 5368, 1500 East Medical Center Drive, Ann Arbor, MI 48109, USA
4Department of Family Medicine, University of Michigan, 1150 W. Medical Center Drive, M7300 Med Sci I, SPC 5625, Ann Arbor, MI 48109, USA

Received 1 December 2015; Revised 11 January 2016; Accepted 20 January 2016

Academic Editor: Wen-Jone Chen

Copyright © 2016 Aya Saeb et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. M. Temiño and R. S. Peebles Jr., “The spectrum and treatment of angioedema,” The American Journal of Medicine, vol. 121, no. 4, pp. 282–286, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Sánchez-Borges, R. Asero, I. J. Ansotegui et al., “Diagnosis and treatment of urticaria and angioedema: a worldwide perspective,” World Allergy Organization Journal, vol. 5, no. 11, pp. 125–147, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Mansi, A. Zanichelli, A. Coerezza et al., “Presentation, diagnosis and treatment of angioedema without wheals: a retrospective analysis of a cohort of 1058 patients,” Journal of Internal Medicine, vol. 277, no. 5, pp. 585–593, 2015. View at Publisher · View at Google Scholar
  4. R. G. Wilkerson, “Angioedema in the emergency department: an evidence-based review,” Emergency Medicine Practice, vol. 14, no. 11, pp. 1–21, 2012. View at Google Scholar · View at Scopus
  5. J. J. Moellman, J. A. Bernstein, C. Lindsell et al., “A consensus parameter for the evaluation and management of angioedema in the emergency department,” Academic Emergency Medicine, vol. 21, no. 4, pp. 469–484, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. R. J. Pickering, J. R. Kelly, R. A. Good, and H. Gewurz, “Replacement therapy in hereditary angioedema: successful treatment of two patients with fresh frozen plasma,” The Lancet, vol. 1, no. 7590, pp. 326–330, 1969. View at Google Scholar
  7. M. Pekdemir, M. Ersel, E. Aksay, S. Yanturali, A. Akturk, and S. Kiyan, “Effective treatment of hereditary angioedema with fresh frozen plasma in an emergency department,” The Journal of Emergency Medicine, vol. 33, no. 2, pp. 137–139, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. M. R. Warrier, C. A. Copilevitz, M. S. Dykewicz, and R. G. Slavin, “Fresh frozen plasma in the treatment of resistant angiotensin-converting enzyme inhibitor angioedema,” Annals of Allergy, Asthma and Immunology, vol. 92, no. 5, pp. 573–575, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Winters, Clinical Practice Guideline: Initial Evaluation and Management of Patients Presenting with Acute Urticaria or Angioedema, AAEM, 2006.
  10. M. Riedl, R. G. Gower, and C. A. Chrvala, “Current medical management of hereditary angioedema: results from a large survey of US physicians,” Annals of Allergy, Asthma and Immunology, vol. 106, no. 4, pp. 316–322.e4, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Caballero, M. Baeza, R. Cabañas et al., “Consensus statement on the diagnosis, management, and treatment of angioedema mediated by bradykinin. Part I. classification, epidemiology, pathophysiology, genetics, clinical symptoms, and diagnosis,” Journal of Investigational Allergology and Clinical Immunology, vol. 21, no. 5, pp. 333–347, 2011. View at Google Scholar · View at Scopus
  12. A. E. Davis III, “New treatments addressing the pathophysiology of hereditary angioedema,” Clinical and Molecular Allergy, vol. 6, article 2, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. M. S. Dykewicz, “Cough and angioedema from angiotensin-converting enzyme inhibitors: new insights into mechanisms and management,” Current Opinion in Allergy and Clinical Immunology, vol. 4, no. 4, pp. 267–270, 2004. View at Google Scholar
  14. N. H. Crooks, J. Patel, L. Diwakar, and F. G. Smith, “Icatibant in the treatment of angiotensin-converting enzyme inhibitor-induced angioedema,” Case Reports in Critical Care, vol. 2014, Article ID 864815, 3 pages, 2014. View at Publisher · View at Google Scholar
  15. M. Prematta, J. G. Gibbs, E. L. Pratt, T. R. Stoughton, and T. J. Craig, “Fresh frozen plasma for the treatment of hereditary angioedema,” Annals of Allergy, Asthma & Immunology, vol. 98, no. 4, pp. 383–388, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Caballero, M. L. Baeza, R. Cabañas et al., “Consensus statement on the diagnosis, management, and treatment of angioedema mediated by bradykinin. Part 2. Treatment, follow-up, and special situations,” Journal of Investigational Allergology and Clinical Immunology, vol. 21, no. 6, pp. 422–441, 2011. View at Google Scholar
  17. H. J. Longhurst, “Emergency treatment of acute attacks in hereditary angioedema due to C1 inhibitor deficiency: what is the evidence?” International Journal of Clinical Practice, vol. 59, no. 5, pp. 594–599, 2005. View at Publisher · View at Google Scholar · View at Scopus